Only an Expert Can Offer Opinions on Obviousness

Feb 25, 2020

Reading Time : 3 min

HVLPO2, LLC (HVO) sued Oxygen Frog for infringement of U.S. Patent Nos. 8,876,941 and 9,372,488, directed to methods and devices for controlling an oxygen-generating system used to manage airflow for torch glass artists. The district court granted summary judgement to HVO and the case proceeded to a jury trial on Oxygen Frog’s assertions that the claims were obvious over two prior art references. At trial, Oxygen Frog introduced deposition testimony of a glass blowing artist whose online video was offered as prior art. The witness had not been qualified as an expert witness, and while proffered as a fact witness, he opined that it would have been obvious to modify a prior art system in a way that matched the claimed invention. HVO objected, arguing improper expert testimony. The district court overruled the objection but provided limiting instruction to the jury that “a witness such as [the glass blowing artist] certainly can offer his observations and explain to you how a system works and what he thinks would occur to him from his perspective would or would not be obvious.” The district court further instructed the jury that the testimony did not answer the ultimate question of obviousness. The jury then found the claims to be obvious. The district court subsequently denied HVO’s motion for a new trial that based upon the artist’s testimony.

On appeal, the Federal Circuit reversed and remanded for a new trial, holding that it was improper to admit the lay witness testimony and that the district court’s limiting instruction was insufficient to cure the substantial prejudice caused by the testimony. The opinion cites Federal Rule of Evidence 702 on expert witness testimony, emphasizing that issues of infringement and validity “are analyzed in great part from the perspective of a person of ordinary skill in the art,” and that a witness who is not “‘qualified as an expert by knowledge, skill, experience, training, or education’ in the pertinent art cannot assist the trier of fact to understand the evidence or to determine a fact in issue.” As a consequence, the Federal Circuit said that allowing a non-expert witness to testify on issues of non-infringement or invalidity is an abuse of discretion.

Citing also to Federal Rule of Civil Procedure 26, the Federal Circuit noted that certain protections are in place with expert witnesses that allow both sides in a case to prepare adequately and without surprise. Here, Oxygen Frog provided neither notice to HVO of anticipated expert testimony nor a written expert report. To contrary, Oxygen Frog argued that it was not required to comply with the Rules governing experts since the witness was not proffered as an expert. Further, according to Oxygen Frog, its witness only offered views based on perception and experience. The Federal Circuit rejected these arguments, stressing that the opinion testimony was directed to the central legal and technical question of the dispute.

The Federal Circuit also dismissed Oxygen Frog’s contention that any error associated with the admission of a lay expert’s testimony was harmless, explaining that by permitting improper testimony, the district court deprived HVO of its right to have the obviousness inquiry decided based on an admissible, qualified expert testimony and prejudiced it by not providing the relevant procedures to ensure the reliability and relevance of the testimony.

While the Federal Circuit acknowledged it might be possible for a district court to cure inadmissible testimony by instructing the jury to disregard it, the error in the present case was not cured and the new trial was necessary.

Practice tip: Determining the expected scope of witness testimony during trial requires care and attention early in the case. To ultimately have a witness opine on questions of validity or infringement, they must be qualified as an expert, and all necessary Federal Rules governing expert witnesses must be adhered to. Failure to do so can be case determinative.

HVLPO2, LLC v. Oxygen Frog, LLC, No. 2019-1649 (Fed. Cir. Feb. 5, 2020)

Share This Insight

Previous Entries

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

IP Newsflash

March 21, 2025

Under the Lanham Act, a plaintiff who prevails on a trademark infringement claim may be entitled to recover the “defendant’s profits” as damages. The Supreme Court in Dewberry Group, Inc. v. Dewberry Engineers Inc. unanimously construed “defendant’s profits” in 35 USC § 1117(a) to mean that only the named defendant’s profits can be awarded, not the profits of other related corporate entities. The Court, however, left open the possibility that other language in § 1117(a) may allow for damages linked to the profits of related entities, if properly raised and supported.

...

Read More

IP Newsflash

March 13, 2025

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

...

Read More

IP Newsflash

March 4, 2025

On February 28, 2025, the USPTO announced that it was rescinding former Director Vidal’s 2022 memorandum on discretionary denials by the Patent Trial and Appeal Board. The 2022 memorandum effectively narrowed the application of discretionary denials in cases with parallel district court litigation by specifying instances where discretionary denial could not be issued. With the withdrawal of the memorandum, individual PTAB panels will regain flexibility in weighing discretionary denials. While the long-term effect of that increased flexibility is not yet known, the immediate effect is likely to be a shift towards the discretionary analysis applied by PTAB panels before the issuance of the memorandum.

...

Read More

IP Newsflash

March 3, 2025

A District of Delaware judge recently granted a defendant’s motion to include a patent prosecution bar in its proposed protective order after determining that litigation counsel’s ability to practice before the Patent Office—without ever having represented the plaintiffs at the Patent Office in the past—weighed heavily in favor of the bar.

...

Read More

IP Newsflash

February 12, 2025

The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to satisfy the written description requirement. In so doing, the Federal Circuit explained that written description and enablement are evaluated based on the subject matter that is claimed, not the products that practice those claims. As a result, the patentee was not required to describe unclaimed, later-discovered features of the accused products despite the broad language in the claims that undisputedly covered the products.

...

Read More

IP Newsflash

January 24, 2025

The District of Delaware recently rejected a patentee’s argument that non-production of an opinion letter from counsel, combined with knowledge of the patent, warranted a finding that defendant induced infringement.

...

Read More

IP Newsflash

January 17, 2025

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought relief under the Safe Harbor Provision of the Hatch-Waxman Act. Specifically, the court found the patentee’s complaint sufficiently alleged at least some uses of the claimed technology that, when taken as true, were not solely uses of a “patented invention” that were “reasonably related” to an FDA submission.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.